PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Feedback
Settings

Settings

Goto Application

1. WO2021242683 - INHIBITION OF ARENAVIRUSES BY COMBINATIONS OF APPROVED THERAPEUTIC DRUGS

Submit observation
PermaLink
Publication Number WO/2021/242683
Publication Date 02.12.2021
International Application No. PCT/US2021/033865
International Filing Date 24.05.2021
IPC
A61K 31/404 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
40having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
403condensed with carbocyclic rings, e.g. carbazole
404Indoles, e.g. pindolol
A61K 31/496 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
A61K 31/4706 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
47Quinolines; Isoquinolines
47064-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
A61K 31/14 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
13Amines, e.g. amantadine
14Quaternary ammonium compounds, e.g. edrophonium, choline
CPC
A61K 31/70
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
Applicants
  • UNIVERSITY OF WASHINGTON [US]/[US]
  • UNIVERSITY OF VIRGINIA PATENT FOUNDATION [US]/[US]
Inventors
  • POLYAK, Stephen, J.
  • HERRING, Shawn
  • WAGONER, Jessica
  • WHITE, Judith
Agents
  • RENZONI, George, E.
Priority Data
63/030,76427.05.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) INHIBITION OF ARENAVIRUSES BY COMBINATIONS OF APPROVED THERAPEUTIC DRUGS
(FR) INHIBITION D'ARÉNAVIRUS PAR DES COMBINAISONS DE MÉDICAMENTS THÉRAPEUTIQUES APPROUVÉS
front page image
Abstract
(EN) Methods for inhibiting or treating viral infection in a subject infected with a virus of the arenaviridae family with a therapeutic agent combination: (a) arbidol and aripiprazole; (b) arbidol and amodiaquine; (c) arbidol and sertraline; (d) arbidol, aripiprazole, and amodiaquine; (e) arbidol, aripiprazole, and sertraline; or (f) aripiprazole and amodiaquine; or pharmaceutically acceptable salts thereof.
(FR) L'invention concerne des méthodes d'inhibition ou de traitement d'une infection virale chez un sujet infecté par un virus de la famille des arenaviridae avec une combinaison d'agents thérapeutiques : (a) arbidol et aripiprazole; (b) arbidol et amodiaquine; (c) arbidol et sertraline; (d) arbidol, aripiprazole et amodiaquine; (e) arbidol, aripiprazole et sertraline; ou (f) aripiprazole et amodiaquine; ou des sels pharmaceutiquement acceptables de ceux-ci.
Latest bibliographic data on file with the International Bureau
# -